VANCOUVER, British Columbia, Sept. 01, 2020 — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVD) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo”) is pleased to announce it has entered into a Letter of Intent with Duquette Consulting LLC (the “LOI”), a company owned by Dan Duquette. Dan Duquette is a twice named Major League Baseball (MLB) Executive of the Year and former Executive Vice-President of the Baltimore Orioles, General Manager of the Montreal Expos, Boston Red Sox, and Milwaukee Brewers (https://en.wikipedia.org/wiki/Dan_Duquette). Dan Duquette has joined forces with Primo Nutraceuticals to partner in the development, sourcing and the global supply of personal protective equipment (“PPE”) products including Primo’s hand sanitizer.
In June 2020 Primo received its first shipment of its lemon hand sanitizer and immediately began sending out samples to procurement departments, receiving positive feedback regarding the quality of the product. Duquette Consulting & their affiliates will help Primo in marketing the hand sanitizer via their partnership channels, marketing brochures & e-commerce sites exposing the Company’s products on a global scale. As Primo is expanding into the Canadian market the Company must have an MDEL (Medical Device Establishment License) to comply with the regulations of Health Canada relating to companies seeking to sell, distribute, manufacture or import medical equipment in Canada. Primo and Duquette Consulting will work towards securing the necessary licenses required to sell nitrile gloves, N95 surgical masks & KN95 masks and gowns. The Company is extremely focused on developing the right partnerships that will encourage the Company’s growth into the market sector of health and wellness. Primo is extremely optimistic that building these strategic types of relationships will prove fruitful for the Company and its shareholders in the very near future.
Duquette Consulting entered the PPE market by sourcing and selling products and supplies at a government & state level to help in the fight against COVID-19, securing, shipping and recently delivering over 5 million masks to the State of Maryland in the United States (the “U.S”). Duquette Consulting partnered with Crowley Worldwide (www.crowley.com) a large logistics conglomerate with over USD $2 billion in annual revenue, offering services to the U.S. Department of Defense, the Department of Homeland Security and other state and federal agencies in the U.S.; top medical equipment suppliers, with financial backing by Citibank. A Duquette Consulting press release is located at the following link: https://dcppe.net/case-study/
The strategic partnership contemplated in the LOI is extremely beneficial for Primo, opening the doors to potential massive orders for the Company’s hand sanitizer worldwide. With the recent issuance of a Government Procurement number to Primo by the Canada Revenue Agency and the LOI with Duquette Consulting LLC, Primo could soon be able to bid on government tenders not only for hand sanitizer, but for N95 surgical masks, KN95 masks, nitrile surgical gloves and gowns. All PPE products would meet the certification standards of the market place including the FDA, CDC, MOD and NIOSH approval requirements.
Richard Cindric, CEO of Primo comments:“We are excited to partner with Mr. Duquette. Together we will provide our line of hand sanitizer to Dan’s already established PPE supply chain processes and distribution network of companies across the U.S.A. and abroad.”
Andy Jagpal, President of Primo comments: “We are extremely pleased to partner with Mr. Duquette to develop a global supply chain of personal protection equipment. We look forward to working with Dan and his team.”
Dan Duquette, CEO Duquette Consulting LLC comments: “Our new partnership with Primo contemplated in the LOI will afford Duquette Consulting the opportunity to broaden our offerings to those in need of PPE. Our recent success in supplying the State of Maryland with over five millions NIOSH approved Surgical Masks is a prime example of our ability to meet the need of institutional buyers who are looking for both quality products from a reputable firm who can deliver in an expedient and cost effective manner. As well as adding in our ability to finance our transactions is a significant differentiator that separates us in the PPE marketplace.”
Joel DeBellefeuille, Director of Primo comments: ”I’ve known Dan for a few years now and I couldn’t be happier to continue working and collaborating with him on amazing deals and partnerships. This is a major plus for Primo and its shareholders. Dan is an extremely influential person with a network of people spanning the globe.”
About Dan Duquette
Dan Duquette is a MLB veteran (Major League Baseball) Executive whose leadership built winning teams and enterprise value of club and media assets over an 18 year career. Successfully executing plans to immediately turn around the Montreal Expos, Boston Red Sox and Baltimore Orioles as entertaining teams to grow fan base, improve revenues, expand market share and improve content distribution. He is also the founder of the Dan Duquette Sports Academy. He has twice been named the Major League Baseball Executive of the Year by Sporting News in 1992 with the Expos and in 2014 with the Baltimore Orioles.
About Duquette Consulting LLC
Duquette Consulting is a management consulting company. With the advent of the worldwide pandemic, we have focused our efforts to help combat the effects of COVID19. In doing so, we established a network of international companies and entities who specialize in supporting the emergency management community in times of crisis. As part of our covid-19 initiative, Duquette Consulting manages and coordinates the procurement and acquisition for both the public and private sectors, domestically and internationally of Personal Protection Equipment (PPE). Our partnership has banking relationships that allow Duquette Consulting’s Partnership group the ability to finance large scale supply of PPE items such as masks, gloves and gowns. Our products are of the highest quality and meet the certifications standards of the marketplace including the FDA, CDC, MOD, and NIOSH approval requirements.
About Primo Nutraceuticals
Primo Nutraceuticals Inc. (“Primo”) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate and farm friendly properties. Primo is dedicated to funding the rapid growth in production, processing, retail and branding of cannabis and cannabis related products in Canada and the United States. Primo has invested in several brands and is pursuing partnerships with retailers and distribution companies in Canada and the United States. Primo’s management is in the process of building a corporate road map to further vertically integrate the Company, specifically by way of “Primo” branded retail outlets – offering “Thrive,” “Primo,” and a selection of curated partner brands. The Company possesses proprietary formulas for cannabis edibles, topical, and tinctures. Primo is focused on building a strong presence in the hemp industry with the objective of extracting and selling cannabinoids (CBD) products in both Canada and the United States.
On behalf of the Board of Directors
PRIMO NUTRACEUTICALS INC.
President and Director
For further information, please contact Zoltan, IR Representative at: 604-722-0305, or; firstname.lastname@example.org.
To learn more about what this news means to the shareholders visit:
FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
No regulatory authority has approved or disapproved the information contained in this news release.